19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Is thymoquinone an antioxidant?

      abstract
      1 , , 1
      BMC Pharmacology
      BioMed Central
      16th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
      25–27 November 2010

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background Thymoquinone is one of the active ingredients of black cumin (Nigella sativa L.) essential oil possessing anti-inflammatory, antineoplastic, neuro- and hepatoprotective properties. Some of these properties were attributed to an antioxidant activity of thymoquinone, which seems to be unlikely from its structure. Because the lipophilic thymoquinone exhibits a structural similarity with the natural mitochondrial electron carrier, ubiquinone, it was of interest whether the suggested antioxidant effect of thymoquinone in cells can be explained by its interaction with the mitochondrial respiratory chain. Materials and methods Antioxidant activities were determined spectrophotometrically by means of the 2,2-diphenyl-1-picrylhydrazyl-radical (DPPH•) assay (516 nm) as well as by the O2 •−-dependent xanthine / xanthine oxidase / cytochrome c assay (550 nm). NADH and succinate:thymoquinone oxidoreductase activities of KCN-blocked (1 mM) submitochondrial particles (0.01 mg/ml) from bovine heart were determined at 340 and 257.5 nm, respectively. Results With the DPPH• assay thymoquinone was shown to be hardly antioxidative. In contrast, thymohydroquinone was even more active than the vitamin E analogon pentamethylchromanol (rate constants for the reaction with DPPH•: 283.7 ± 1.9 M−1 s−1 (3) vs. 236.2 ± 4.7 M−1 s−1 (6); data are means ± SEM (n). The cytochrome c system turned out to be unsuitable for the evaluation of the antioxidant activity of thymoquinone. Thymoquinone concentration-dependently (20–1000 µM) stimulated the NADH (150 µM) oxidation of submitochondrial particles to Vmax values of around 400 nmol per min per mg protein. KM values were 77.4 µM for thymoquinone and 6.4 µM for NADH. The thymoquinone-stimulated NADH oxidation was sensitive to inhibitors of the mitochondrial electron transfer (90% inhibition with 0.2 µM rotenone, 49% inhibition with 1 µM antimycin A, 82% inhibition with 1 µM antimycin A + 1 µM myxothiazol; 100 µM thymoquinone). In addition to its stimulatory effect on NADH:quinone oxidoreductase, thymoquinone (50 µM) was reduced to its hydroquinone by rotenone- (0.2 µM) and KCN-inhibited submitochondrial particles when succinate (10 mM) was used as substrate. This reduction was sensitive to antimycin A and myxothiazol, inhibitors of mitochondrial complex III. Conclusions Thymoquinone (oxidized form) possesses a very low antioxidant activity while its reduced form (thymohydroquinone) exerts a high radical-scavenging capacity, comparable to that of pentamethylchromanol, a short-chain tocopherol analogon. We assume that the mitochondrial respiratory chain is significant for the antioxidant properties of thymoquinone in the cell by converting the administered thymoquinone into its hydroquinone.

          Related collections

          Author and article information

          Conference
          BMC Pharmacol
          BMC Pharmacology
          BioMed Central
          1471-2210
          2010
          16 November 2010
          : 10
          : Suppl 1
          : A9
          Affiliations
          [1 ]Molecular Pharmacology and Toxicology Unit, Department of Biomedical Sciences, University of Veterinary Medicine, 1210 Vienna, Austria
          Article
          1471-2210-10-S1-A9
          10.1186/1471-2210-10-S1-A9
          3016565
          eab4b892-274b-4190-bf8b-570d68c0d9fb
          Copyright ©2010 Staniek and Gille; licensee BioMed Central Ltd.
          16th Scientific Symposium of the Austrian Pharmacological Society (APHAR)
          Vienna, Austria
          25–27 November 2010
          History
          Categories
          Meeting Abstract

          Pharmacology & Pharmaceutical medicine
          Pharmacology & Pharmaceutical medicine

          Comments

          Comment on this article